50+ professional R&D analysis team, experienced engineer combination. There are a total of 6,600 square meters of standardized laboratories for product development laboratories, analysis laboratories, synthesis laboratories and pilot scale-up laboratories.
High-throughput, flow chemistry platform + AI-powered intelligent reaction workstation. It is equipped with a number of 20~100L reactors, Corning microchannel reactors and other process development devices.
Equipped with more than 30 analytical equipment such as NMRIC, ICP-MS, GC-MS, LC-MS, HPLC, GC, etc., with data guaranteed.
*Some commonly used instruments are displayed as follows.
The Titan Songjiang Integrated Base carries the R&D, production and manufacturing of high-end reagents, special proteases, molecular biological reagents, high-end water purification instruments and other products. It is equipped with comprehensive functional carriers including automated high-level warehouses and clean areas to stabilize and improve the Yangtze River Delta service system.
On December 3, 2021, TitanSCI officially announced the acquisition of 77.5543% of the equity of Anhui TEDIA High Purity Solvent Co., Ltd., which is controlled by the United States. Anhui TEDIA is equipped with advanced R&D center laboratory, DCS automatic production management system of the whole process, and is equipped with a high-speed automatic filling line with exclusive design.
It mainly produces liquid chromatography grade, pesticide residue grade, anhydrous grade, biological grade, preparative grade, pharmaceutical grade high-purity solvent and some standard products, TEDIA is currently a liquid chromatography grade high-purity solvent manufacturer with a large market share in China.
The production and manufacturing system is upgraded. After it is put into operation, the production capacity for general reagents can reach 46,000 tons per year and high-end reagents 6,000 tons. In this way, we can better serve the customized needs of key customers. The professional logistics scale is expanded due to all-category warehouses, Class A warehouses and geographical and transportation advantages.
Located in the Fengxian Comprehensive Bonded Zone, the factory includes a high-specification standard workshop, a clean production area, a verification center, Class A and Class C workshops and warehouses, fully equipped for functional use. With the arrival of Titan Pure Source, RADOBIO, MAGAL and CLINX, it will establish an intelligent, large-scale production and export base of domestic life science where the process of analysis is particularly complete.
Micro-source Testing is a third-party R&D and testing service company invested by TitanSCI.It can provide impurity research under various relevant regulatory requirements, and focus on providing a series of complete solutions such as evaluation report, method development, validation and sample testing for impurities that may be generated in the production process of products.
Micro-source Testing complies with ISO 17025 and GMP for laboratory management, and has applied for and passed the China Metrology Accreditation (CMA) and CNAS qualification certification. The instruments and equipment are verified by IQ/OQ/PQ, and the relevant instrument operating procedures and metrology certifications are established. At present, there are 71 sets of LC-MS/MS and other precision analytical instruments, and a total of 9,320 testing and R&D projects have been successfully completed. (Data as of June 30, 2022)
Founded in 2015, Hzymes, invested by TitanSCI, is a high-tech enterprise specializing in the R&D, production, application and technical services of core raw materials for biomedicine and in vitro diagnostics, and has set up R&D and production centers in Shanghai, Wuhan, Suzhou, Qingdao and Yichang.
Hzymes has technology platforms such as enzyme gene mining and performance characterization, enzyme molecule optimization and modification, enzyme gene high-throughput screening, organic synthesis, synthetic biology, antigen and antibody R&D and preparation, etc., providing key enzyme products for biopharmaceuticals and in vitro diagnostics.
TitanSCI has an annual production capacity of 1500kg of deuterated products, of which the purity of the main product deuterated chloroform is as high as 99.8%, and the deuteration degree is ≥ 99.8%, which is better than commercial products, and greatly improves the utilization of raw materials and heavy water, so that its production cost is only 50% of imported products.
Cuiying Chemical has 5,000 square meters of R&D, pilot plant and office space, and the analysis room is equipped with Bruker400M and Varian400M nuclear magnetic resonance spectrometers, Agilent gas chromatographs, gas chromatography-mass spectrometers, liquid chromatography-mass spectrometers, Metrohm moisture analyzers and other testing equipment, which can realize the scale-up of samples from small-scale to pilot-scale and realize the seamless connection from laboratory technology to industrial process.
Founded in 2011, Ideaoptics, invested by TitanSCI, with the mission of promoting the progress of photonics technology, researches deep spectroscopy technology, starts from the principle of equipment, goes deep into the underlying technology research, masters the core technology platform. It provides spectral detection products and solutions for scientific research and innovation and the semiconductor industry, and is a key cultivation partner in the supply chain of domestic semiconductor companies such as SMIC.
Miaoshun (Shanghai) Biotechnology Co., Ltd., headquartered in Shanghai Zhangjiang Science City, is a high-tech enterprise integrating R&D, production and sales in the field of biomedicine. Miaoshun Biotech focuses on the research and development of national brand cell models, and carries out import substitution work by building The Primary Cell Solution-TPCS® independent research and development brand. It breaks the monopoly of cell technology in the Chinese market by developed countries in the United States and Europe, aiming to solve the "bottleneck" link in the upstream of China's biomedical industry chain and empower the domestic innovative drug R&D industry.
Founded in 2012, Magal is committed to manufacturing innovative centrifuges with high quality. Including high-speed and low-speed multifunctional centrifuges, high-speed freezing centrifuges, mini centrifuges and so on. IS09001:2015, CE and IS013485:2016 certified, Magal has also filed Class I medical devices, as well as the production.
Founded in 2016, Radobio is an innovative technology enterprise committed to the R&D and production of bioengineering equipment. It focuses on the development of culture environment control techniques such as temperature, humidity, gas concentration and dynamic and static state for animal and microbial cell culture, providing many effective solutions for cell culture users. The product lines include cell incubators, constant temperature and humidity boxes, biosafety cabinets and so on.
Founded in 2006, Clinx is a high-tech enterprise integrating R&D, production, sales and service, which is dedicated to providing professional solutions of digital imaging system and image analysis for life science. The product lines include gel imaging system, fluorescence and chemiluminescence imaging system, plant imaging system, small animal imaging system, live cell imaging system and so on. In 2015, Clinx won the honorary title of “High-tech Enterprise”. In 2019, Clinx was selected as one of the specialized and sophisticated enterprises in Shanghai.